Get the Stockscreener App
2.585
0.58%
0.015
After Hours:
2.59
0.005
+0.19%
Armata Pharmaceuticals Inc stock is traded at $2.585, with a volume of 14,218.
It is up +0.58% in the last 24 hours and up +19.12% over the past month.
Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections in the United States. The company develops its products using its proprietary bacteriophage-based technology. Its product candidate is the AP-SA01 that targets Staphylococcus aureus, including multidrug-resistant strains. The company is also developing and advancing synthetic phage for treating diseases caused by pseudomonas aeruginosa. Armata Pharmaceuticals, Inc. is headquartered in Marina del Rey, California.
See More
Previous Close:
$2.57
Open:
$2.6
24h Volume:
14,218
Relative Volume:
0.06
Market Cap:
$93.56M
Revenue:
-
Net Income/Loss:
$-41.36M
P/E Ratio:
-1.5762
EPS:
-1.64
Net Cash Flow:
$-42.09M
1W Performance:
+7.71%
1M Performance:
+19.12%
6M Performance:
+26.72%
1Y Performance:
+5.94%
1-Day Range:
$2.58
$2.6999
1-Week Range:
$2.40
$2.72
52-Week Range:
$0.8981
$2.96
Armata Pharmaceuticals Inc Stock (ARMP) Company Profile
Name
Armata Pharmaceuticals Inc
Sector
Industry
Phone
310-655-2928
Address
4503 Glencoe Avenue, Marina del Rey, CA
Compare ARMP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ARMP
Armata Pharmaceuticals Inc
|
2.585 | 93.02M | 0 | -41.36M | -42.09M | -1.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
385.65 | 96.11B | 11.42B | 3.64B | -1.26B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
555.13 | 60.40B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
428.14 | 54.91B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
673.15 | 41.30B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
298.52 | 33.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Armata Pharmaceuticals Inc Stock (ARMP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-19-19 | Initiated | Ladenburg Thalmann | Buy |
Armata Pharmaceuticals Inc Stock (ARMP) Latest News
Will Armata Pharmaceuticals Inc. stock benefit from interest rate changesFree Consistent Gain Investment Strategies - Newser
Will Armata Pharmaceuticals Inc. rebound enough to break evenAI Screener for Daily Stock Forecast - Newser
What data driven models say about Armata Pharmaceuticals Inc.’s futureReal Market Tracker with Price Action Tools - Newser
Measuring Armata Pharmaceuticals Inc.’s beta against major indicesFree Capital Preserving Trade Plan Templates - Newser
Statistical indicators supporting Armata Pharmaceuticals Inc.’s strengthFree Early Breakout Entry Point Notifications - Newser
Has Armata Pharmaceuticals Inc. formed a bullish divergenceHigh Win Rate Strategy with Stop Protection - Newser
Why Armata Pharmaceuticals Inc. stock attracts strong analyst attentionWeekly Hot Stocks Based on Volume Flow - Newser
Combining machine learning predictions for Armata Pharmaceuticals Inc.Risk Aware Swing Trade Analysis Insights - Newser
Using economic indicators to assess Armata Pharmaceuticals Inc. potentialAI Stock Movement Forecast with Accuracy - Newser
How to build a custom watchlist for Armata Pharmaceuticals Inc.Free Entry Alert With Low Drawdown Strategy - Newser
Combining price and volume data for Armata Pharmaceuticals Inc.3-Year Equity Summary With Setup Insights - Newser
Armata Pharmaceuticals Inc. stock outlook for YEARIntelligent Trade Forecast With AI Analytics - Newser
Using RSI to spot recovery in Armata Pharmaceuticals Inc.Free Entry Alert Based on Volume Spikes - Newser
Can machine learning forecast Armata Pharmaceuticals Inc. recoveryWeekly Stock Market Strategy Summary - Newser
When is Armata Pharmaceuticals Inc. stock expected to show significant growthStay informed with expert market forecasts - Jammu Links News
Price momentum metrics for Armata Pharmaceuticals Inc. explainedEntry Zone Forecast for Momentum Trading - Newser
Armata Pharmaceuticals Inc. Stock Analysis and ForecastGain access to exclusive stock analysis - Jammu Links News
Is Armata Pharmaceuticals Inc. a growth stock or a value stockInvest confidently with real-time data analysis - Jammu Links News
What is the dividend policy of Armata Pharmaceuticals Inc. stockInvest confidently with professional market insights - Jammu Links News
What are analysts’ price targets for Armata Pharmaceuticals Inc. in the next 12 monthsInvest with confidence backed by data - Jammu Links News
What drives Armata Pharmaceuticals Inc. stock priceBuild a winning portfolio with smart picks - Jammu Links News
How strong is Armata Pharmaceuticals Inc. company’s balance sheetUnlock exclusive investment alerts - Jammu Links News
Price action breakdown for Armata Pharmaceuticals Inc.Free Stock Selection With High Accuracy - Newser
Applying chart zones and confluence areas to Armata Pharmaceuticals Inc.Free Accurate Buy Point for Momentum Stocks - Newser
What are Armata Pharmaceuticals Inc. company’s key revenue driversDouble-digit growth - Jammu Links News
Should I hold or sell Armata Pharmaceuticals Inc. stock in 2025Get daily updates on promising stocks - Jammu Links News
Why is Armata Pharmaceuticals Inc. stock attracting strong analyst attentionMaximize gains with strategic stock entries - Jammu Links News
How Efficient Is Armata Pharmaceuticals Inc. at Controlling Operating CostsAI Volatility Forecast and Risk Monitor - Newser
How Armata Pharmaceuticals Inc. stock performs during market volatilityMinimal Risk Growth Investment Opportunity Analysis - newser.com
What is the risk reward ratio of investing in Armata Pharmaceuticals Inc. stockFree Stock Market Return Analysis - Jammu Links News
What catalysts could drive Armata Pharmaceuticals Inc. stock higher in 2025Capitalize on emerging market sectors - Jammu Links News
Is it the right time to buy Armata Pharmaceuticals Inc. stockAchieve rapid wealth accumulation through smart investing - Jammu Links News
How volatile is Armata Pharmaceuticals Inc. stock compared to the marketUnlock powerful market insights for success - Jammu Links News
What makes Armata Pharmaceuticals Inc. stock price move sharplyGain insights from top financial experts - Jammu Links News
What is Armata Pharmaceuticals Inc. company’s growth strategyAchieve exceptional returns with expert guidance - Jammu Links News
Sectors Driving Future Growth for Armata Pharmaceuticals Inc. StockFree AI Powered High Return Stock Calls - Newser
Armata Pharmaceuticals Inc Stock (ARMP) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.10%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):